158
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion

&
Pages 543-553 | Received 15 Jul 2005, Accepted 03 Oct 2005, Published online: 08 Oct 2008

References

  • Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A. Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991; 1066: 29–36
  • De Vleeschauwer D, Van der Meeren P. Colloid chemical stability and interfacial properties of mixed phospholipid-non-ionic surfactant stabilized oil-in-water emulsions. Colloids Surf A: Physicochem Eng Aspects 1999; 152: 59–66
  • Eisenberg M, Gresalfi T, Riccio T, McLaughlin S. Adsorption of monovalent cations to bilayer membranes containing negative phospholipids. Biochemistry 1979; 16: 5213–5223
  • Francis GE, Delgado C, Fisher D, Malik F, Agrawal AK. Polyethylene glycol modification: Relevance of improved methodology to tumor targeting. J Drug Target 1996; 3: 321–340
  • Hande KR. Etoposide pharmacology. Semin Oncol 1992; 19(suppl 13)3–9
  • Hultin M, Carneheim C, Rosenqvist K, Olivecrona T. Intravenous lipid emulsions: Removal mechanisms as compared to chylomicrons. J Lipid Res 1995; 36: 2174–2184
  • Igarashi R, Takenaga M, Matsuda T. Distribution of the lipid microspheres preparation. Adv Drug Deliv Rev 1996; 20: 147–154
  • Ishida T, Harashima H, Kiwada H. Interaction of liposomes with cells in vitro and in vivo: Opsonins and receptors. Curr Drug Metab 2001; 2: 397–409
  • Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994; 271: 58–65
  • Kimura A, Yamaguchi H, Watanabe K, Hayashi M, Awazu S. Factors influencing the tissue distribution of coenzyme Q10 intravenously administered in an emulsion to rats: Emulsifying agents and lipoprotein lipase activity. J Pharm Pharmacol 1986; 38: 659–662
  • Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001; 47: 65–81
  • Lasic DD, Martin FJ, Gabizon A, Huang SK, Papahadjopoulos D. Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta 1991; 1070: 187–192
  • Lundberg BB. The solubilization of lipophilic derivatives of podophyllotoxins in sub-micron sized lipid emulsions and their cytotoxic activity against cancer cells in culture. Int J Pharm 1994; 109: 73–81
  • Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989; 6: 193–210
  • Mizushima Y, Hamano T, Yokoyama K. Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann Rheum Dis 1982; 41: 263–267
  • Mizushima Y, Hoshi K. Review: recent Advances in lipid microspheres technology for targeting prostaglandin delivery. J Drug Target 1993; 1: 93–100
  • O'Dwyer PJ, Weiss RB. Hypersensitivity reactions induced by etoposide. Cancer Treat Rep 1984; 68: 959–961
  • Papahadjopoulos D, Allen TM, Gabizon A, Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991; 24: 11460–11464
  • Papahadjopoulos D. Surface properties of acidic phospholipids: Interaction of monolayers and hydrated liquid crystals with uni- and bivalent metal ions. Biochim Biophys Acta 1968; 163: 240–254
  • Patlolla RR, Venkateswarlu V. Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. J Pharm Sci 2005; 94: 437–445
  • Schroeder U, Sommerfield P, Ulrich S, Sabel BA. Nanoparticle technology for delivering of drug across the blood-brain barrier. J Pharm Sci 1998; 87: 1305–1307
  • Sengupta S, Tyagi P, Chandra S, Kochupillai V, Gupta SK. Encapsulation in cationic liposomes enhances antitumor efficiency and reduces the toxicity of Etoposide, a topo-isomerase-II inhibitor. Pharmacology 2001; 62: 163–171
  • Sengupta S, Tyagi P, Velpandian T, Gupta YK, Gupta SK. Etoposide encapsulated in positively charged liposomes: Pharmacokinetic studies in mice and formulation stability studies. Pharmacol Res 2000; 42: 459–464
  • Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicty of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly (ethylene glycol) coated vesicles. Biochim Biophys Acta 1991; 1062: 77–82
  • Shimada K, Miyagishima A, Sadzuka Y, Nozawa Y, Mochizuki Y, Ohshima H, Hirota S. Determination of the thickness of fixed aqueous layer around polyethyleneglycol-coated liposomes. J Drug Target 1995; 24: 257–263
  • Smit EF, Carney DN, Hurford P, Sleijfer DT, Postmos PE. Phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax 1989; 44: 631–633
  • Takeuchi H, Kojima H, Yamamoto H, Kawashima Y. Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. J Controlled Release 2001; 75: 83–91
  • Takino T, Konishi K, Takakura Y, Hashida M. Long circulating emulsion carrier system for highly lipophilic drugs. Biol Pharm Bull 1994; 17: 121–125
  • Takino T, Nakajima C, Takakura Y, Sezaki H, Hashida M. Controlled biodistribution of highly lipophilic drugs with various parenteral formulation. J Drug Target 1993; 1: 117–124
  • Tashima S. Safety and efficacy of intraperitoneal injection of etoposide in oil suspension in mice with peritoneal carcinomatosis. Cancer Chemother Pharmacol 1995; 36: 211–216
  • Valduga CJ, Fernandes DC, Lo Prete AC, Azevedo CH, Rodrigues DG, Maranhaao RC. Use of cholesterol-rich microemulsions that binds to low-density lipoprotein receptors as vehicle for etoposide. J Pharm Pharmacol 2003; 55: 1615–1622
  • Veerareddy PR, Venkateswarlu V. Formulation and evaluation of oil-in-water emulsions of piperine in visceral leishmniasis. Pharmazie 2004; 59: 194–197
  • Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Controlled Release 2004; 95: 627–638
  • Venkateswarlu V, Patlolla RR. Lipid microspheres as drug delivery systems. Ind J Pharm Sci 2001; 63: 450–458
  • Verway EJW, Overbeek JTG. Theory of the stability of lyophobic colloids. Elsevier, Amsterdam, NY 1948
  • Washington C, Chawla A, Christy N, Davis SS. The electrokinetic properties of phospholipid-stabilized fat emulsions. Int J Pharm 1989; 54: 191–197
  • Washington C, Davis SS. Ageing effects in parenteral fat emulsions: The role of fatty acids. Int J Pharm 1987; 39: 33–37
  • Washington C. The electrokinetic properties of phospholipid-stabilized fat emulsions. II Droplet mobility in mixed electrolytes. Int J Pharm 1990; 58: 13–18
  • Woodle MC, Collins LR, Sponsier E, Kossovsky N, Papahadjopoulos D, Martin FJ. Sterically stabilized liposomes: Reduction in electrophoretic mobility but not electrostatic surface potential. Biophys J 1992; 61: 902–910
  • Yamaguchi H, Watanabe K, Hayashi M, Awazu S. Effect of egg yolk phospholipids plasma elimination and tissue distribution of coenzyme Q10 administered in an emulsion to rats. J Pharm Pharmacol 1984; 36: 768–769
  • Yamaguchi T, Tanabe N, Fukushima Y, Nasu T, Hayashi H. Distribution of prostaglandin E1 in lipid emulsions in relation to release rate from lipid particles. Chem Pharm Bull 1994; 42: 646–650
  • Yanagikawa A. Application of lipid particles as a novel carrier for various drugs. Jpn J Inflam 1982; 2: 251–257
  • Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. Vascular permeability in a human tumor xenograft: Molecular size dependence and cut off size. Cancer Res 1995; 55: 3752–3756

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.